Mutations in FARS2 and non-fatal mitochondrial dysfunction in two siblings

Research output: Contribution to journalArticle

Abstract

Recently, mutations in FARS2, which encodes for mitochondrial phenylalanyl-tRNA synthetase, have been implicated in autosomal recessive combined oxidative phosphorylation deficiency 14. Associated clinical features in three previously reported patients with confirmed FARS2 mutations include infantile onset epilepsy, and a fatal Alpers-like encephalopathy. Herein, we report on two siblings with global developmental delay, dysarthria and tremor and compound heterozygous FARS2 abnormalities. They have a heterozygous missense mutation, c.1255C>T which predicts p.Arg419Cys in exon 7 of FARS2, inherited from their father and uncovered on exome sequencing, and an interstitial deletion of chromosome 6p25.1 inherited from their mother and uncovered on SNP array. This interstitial deletion includes all of exon 6 and parts of introns 5 and 6 of FARS2. Biochemical studies were also consistent with a mitochondrial disorder. While these siblings had considerable developmental difficulties, they are making consistent developmental progress and appear to be considerably less severely affected than the other patients reported in the literature with FARS2 associated mitochondrial disease. Thus, this study expands the phenotypic spectrum of FARS2 related disease and emphasizes intragenic deletion in the list of causative mutations.

Original languageEnglish (US)
Pages (from-to)1147-1151
Number of pages5
JournalAmerican Journal of Medical Genetics, Part A
Volume167
Issue number5
DOIs
StatePublished - May 1 2015

    Fingerprint

Keywords

  • Exome sequencing
  • FARS2
  • Mitochondrial tRNA synthetase

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this